$CLIR
ClearSign Technologies Corp

2022 Q3 Form 10-Q Financial Statement

#000155837022013628 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4
Revenue $324.0K $0.00 $54.00K
YoY Change 70.53%
Cost Of Revenue $201.0K $0.00 $51.00K
YoY Change -27.7% -100.0% -79.6%
Gross Profit $123.0K $0.00 $3.000K
YoY Change -239.77% -100.0% -101.19%
Gross Profit Margin 37.96% 5.56%
Selling, General & Admin $1.461M $1.472M $984.0K
YoY Change 29.18% -5.94% -15.9%
% of Gross Profit 1187.8% 32800.0%
Research & Development $97.00K $188.0K $244.0K
YoY Change -91.48% -60.17% -44.55%
% of Gross Profit 78.86% 8133.33%
Depreciation & Amortization $41.00K $36.00K $45.00K
YoY Change -66.67% -14.29% -10.0%
% of Gross Profit 33.33% 1500.0%
Operating Expenses $1.558M $1.660M $1.228M
YoY Change -31.34% -18.51% -23.44%
Operating Profit -$1.435M -$1.660M -$1.225M
YoY Change -39.12% -34.7% -34.0%
Interest Expense $35.00K $1.000K
YoY Change
% of Operating Profit
Other Income/Expense, Net $123.0K $22.00K $248.0K
YoY Change 2975.0% -91.24%
Pretax Income -$1.312M -$1.638M -$1.227M
YoY Change -44.24% -28.5% -34.03%
Income Tax
% Of Pretax Income
Net Earnings -$1.312M -$1.638M -$1.227M
YoY Change -44.24% -28.5% -33.82%
Net Earnings / Revenue -404.94% -2272.22%
Basic Earnings Per Share -$0.03 -$0.05 -$0.04
Diluted Earnings Per Share -$0.03 -$0.05 -$38.86K
COMMON SHARES
Basic Shares Outstanding 37.95M 33.54M 31.57M
Diluted Shares Outstanding 37.87M 33.54M

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.780M $9.007M $7.607M
YoY Change 10.62% -15.36% -13.75%
Cash & Equivalents $5.880M $9.007M $7.607M
Short-Term Investments $3.900M
Other Short-Term Assets $506.0K $605.0K $345.0K
YoY Change 678.46% 10.6% 74.24%
Inventory
Prepaid Expenses $345.0K
Receivables $38.00K $486.0K $33.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $10.61M $10.10M $8.024M
YoY Change 14.11% -10.61% -14.47%
LONG-TERM ASSETS
Property, Plant & Equipment $427.0K $477.0K $530.0K
YoY Change -35.01% -29.44% 24.12%
Goodwill
YoY Change
Intangibles $818.0K $812.0K $799.0K
YoY Change -13.16% -37.35% -38.63%
Long-Term Investments
YoY Change
Other Assets $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $1.255M $1.299M $1.339M
YoY Change -22.0% -34.46% -23.0%
TOTAL ASSETS
Total Short-Term Assets $10.61M $10.10M $8.024M
Total Long-Term Assets $1.255M $1.299M $1.339M
Total Assets $11.86M $11.40M $9.363M
YoY Change 8.78% -14.17% -15.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $287.0K $356.0K $224.0K
YoY Change 4.74% -20.54% -48.51%
Accrued Expenses $300.0K $285.0K $218.0K
YoY Change -50.5% -26.92% -42.93%
Deferred Revenue $61.00K $84.00K $84.00K
YoY Change 75.0% -10.64%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $828.0K $952.0K $731.0K
YoY Change -23.48% -12.18% -32.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $239.0K $252.0K $350.0K
YoY Change -40.69% -44.49% 40.0%
Total Long-Term Liabilities $239.0K $252.0K $350.0K
YoY Change 39.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $828.0K $952.0K $731.0K
Total Long-Term Liabilities $239.0K $252.0K $350.0K
Total Liabilities $1.067M $1.204M $1.081M
YoY Change -28.15% -21.72% -31.58%
SHAREHOLDERS EQUITY
Retained Earnings -$87.20M -$85.90M -$82.77M
YoY Change 6.94% 8.48% 10.54%
Common Stock $4.000K $4.000K $3.000K
YoY Change 33.33% 33.33% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.80M $10.19M $8.282M
YoY Change
Total Liabilities & Shareholders Equity $11.86M $11.40M $9.363M
YoY Change 8.78% -14.17% -15.81%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income -$1.312M -$1.638M -$1.227M
YoY Change -44.24% -28.5% -33.82%
Depreciation, Depletion And Amortization $41.00K $36.00K $45.00K
YoY Change -66.67% -14.29% -10.0%
Cash From Operating Activities -$917.0K -$1.844M -$1.165M
YoY Change -50.91% -14.79% -35.99%
INVESTING ACTIVITIES
Capital Expenditures -$41.00K -$40.00K -$78.00K
YoY Change 0.0% 900.0% 160.0%
Acquisitions
YoY Change
Other Investing Activities -$3.900M $14.00K
YoY Change
Cash From Investing Activities -$3.941M -$26.00K -$78.00K
YoY Change 9512.2% 550.0% 160.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.741M 4.220M 0.000
YoY Change 1512.04% 102.3% -100.0%
NET CHANGE
Cash From Operating Activities -917.0K -1.844M -1.165M
Cash From Investing Activities -3.941M -26.00K -78.00K
Cash From Financing Activities 1.741M 4.220M 0.000
Net Change In Cash -3.117M 2.350M -1.243M
YoY Change 73.07% -2965.85% -31.33%
FREE CASH FLOW
Cash From Operating Activities -$917.0K -$1.844M -$1.165M
Capital Expenditures -$41.00K -$40.00K -$78.00K
Free Cash Flow -$876.0K -$1.804M -$1.087M
YoY Change -52.05% -16.48% -39.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33541408
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31314816
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31314816
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33378054
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30922871
dei Entity Central Index Key
EntityCentralIndexKey
0001434524
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
clir Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
P0Y
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
clir Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm
P0Y
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35521
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2056298
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84000
dei Entity Registrant Name
EntityRegistrantName
CLEARSIGN TECHNOLOGIES CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
952000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
731000
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36349881
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31581666
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
dei Document Type
DocumentType
10-Q
dei Entity Address Address Line1
EntityAddressAddressLine1
8023 E. 63rd Place, Suite 101
dei Entity Address City Or Town
EntityAddressCityOrTown
Tulsa
dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
74133
dei City Area Code
CityAreaCode
206
dei Local Phone Number
LocalPhoneNumber
673-4848
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
CLIR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37951559
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9007000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7607000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33000
CY2022Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
486000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
39000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
605000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
345000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
10098000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
8024000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
477000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
530000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
812000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
799000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000
CY2022Q2 us-gaap Assets
Assets
11397000
CY2021Q4 us-gaap Assets
Assets
9363000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
356000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
224000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
227000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
205000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
252000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
350000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
8282000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
285000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
218000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10193000
CY2022Q2 us-gaap Liabilities
Liabilities
1204000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8282000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11397000
CY2021Q4 us-gaap Liabilities
Liabilities
1081000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9363000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
363000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36349881
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31581666
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
4000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
96083000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91035000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
505000
us-gaap Profit Loss
ProfitLoss
-4312000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
9000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-85893000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82765000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10193000
us-gaap Cost Of Revenue
CostOfRevenue
730000
CY2021Q2 us-gaap Gross Profit
GrossProfit
-505000
us-gaap Gross Profit
GrossProfit
-367000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
188000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
472000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
296000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1298000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1472000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1565000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2881000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2898000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1660000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
2037000
us-gaap Operating Expenses
OperatingExpenses
3177000
us-gaap Operating Expenses
OperatingExpenses
4196000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1660000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2542000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3177000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4563000
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
251000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
251000
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
14000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
37000
CY2022Q2 us-gaap Other Income
OtherIncome
8000
us-gaap Other Income
OtherIncome
12000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
251000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
49000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
251000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1638000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2291000
us-gaap Net Income Loss
NetIncomeLoss
-3128000
us-gaap Net Income Loss
NetIncomeLoss
-4312000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-1638000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-2290000
us-gaap Profit Loss
ProfitLoss
-3128000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q1 clir Share Issued For At Market Issuance1.24 Per Share
ShareIssuedForAtMarketIssuance1.24PerShare
1.24
CY2022Q1 clir Shares Issued Through Use Of At Market Issuance
SharesIssuedThroughUseOfAtMarketIssuance
578000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q1 clir Common Stock For Services Per Share Issue One
CommonStockForServicesPerShareIssueOne
1.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33541408
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33378054
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30922871
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8282000
CY2022Q1 clir Common Stock Issued For Exercise Of Options0.89 Per Share
CommonStockIssuedForExerciseOfOptions0.89PerShare
0.89
CY2022Q1 clir Common Stock Issued For Exercise Of Options2.93 Per Share
CommonStockIssuedForExerciseOfOptions2.93PerShare
2.93
CY2022Q1 clir Stock Issued During Period Value In Payments Of Accrued Compensation
StockIssuedDuringPeriodValueInPaymentsOfAccruedCompensation
95000
CY2022Q1 clir Stock Options Granted In Payment Of Accrued Compensation Fair Value
StockOptionsGrantedInPaymentOfAccruedCompensationFairValue
12000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
80000
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1490000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7564000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50000
CY2022Q2 clir Share Issued For At Market Issuance1.71 Per Share
ShareIssuedForAtMarketIssuance1.71PerShare
-1.71
CY2022Q2 clir Shares Issued Through Use Of At Market Issuance
SharesIssuedThroughUseOfAtMarketIssuance
9000
CY2022Q2 clir Common Stock For Services Per Share Issue One
CommonStockForServicesPerShareIssueOne
1.93
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7000
CY2022Q2 clir Shares Issued Stock Offering Price Per Share
SharesIssuedStockOfferingPricePerShare
-1.11
CY2022Q2 clir Stock Issued During Period Value Stock Offering
StockIssuedDuringPeriodValueStockOffering
4211000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-1638000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10193000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9541000
CY2021Q1 clir Common Stock Issued For Exercise Of Options1.90 Per Share
CommonStockIssuedForExerciseOfOptions1.90PerShare
1.90
CY2021Q1 clir Stock Issued During Period Value Stock Options Exercised1.90 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.90PerShare
2000
CY2021Q1 clir Common Stock Issued For Exercise Of Options3.80 Per Share
CommonStockIssuedForExerciseOfOptions3.80PerShare
3.80
CY2021Q1 clir Stock Issued During Period Value Stock Options Exercised3.80 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised3.80PerShare
36000
CY2021Q1 clir Common Stock Issued For Exercise Of Options1.21 Per Share
CommonStockIssuedForExerciseOfOptions1.21PerShare
1.21
CY2021Q1 clir Stock Issued During Period Value Stock Options Exercised1.21 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.21PerShare
4000
CY2021Q1 clir Common Stock Issued For Exercise Of Options1.80 Per Share
CommonStockIssuedForExerciseOfOptions1.80PerShare
1.80
CY2021Q1 clir Shares Issued Upon Exercise Of Warrants
SharesIssuedUponExerciseOfWarrants
67000
CY2021Q1 clir Adjustments To Additional Paid In Capital Share Based Payment Arrangement Option Increase For Cost Recognition Two
AdjustmentsToAdditionalPaidInCapitalShareBasedPaymentArrangementOptionIncreaseForCostRecognitionTwo
210000
CY2021Q1 clir Stock Issued During Period Value In Payments Of Accrued Compensation
StockIssuedDuringPeriodValueInPaymentsOfAccruedCompensation
217000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
410000
CY2021Q1 clir Shares Issued Through Use Of At Market Issuance
SharesIssuedThroughUseOfAtMarketIssuance
4469000
CY2021Q1 clir Proceeds Receivable From At Market Issuance
ProceedsReceivableFromAtMarketIssuance
1076000
CY2021Q1 clir Shares Issued For Services Per Share
SharesIssuedForServicesPerShare
2.33
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
9000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-2021000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11868000
CY2021Q2 clir Common Stock For Services3.10 Per Share Issue
CommonStockForServices3.10PerShareIssue
3.10
CY2021Q2 clir Stock Issued During Period Value Stock Options Exercised3.10 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised3.10PerShare
54000
CY2021Q2 clir Common Stock For Services0.89 Per Share Issue
CommonStockForServices0.89PerShareIssue
0.89
CY2021Q2 clir Shares Issued For Services0.89 Per Share
SharesIssuedForServices0.89PerShare
36000
CY2021Q2 clir Common Stock For Services1.85 Per Share Issue
CommonStockForServices1.85PerShareIssue
1.85
CY2021Q2 clir Shares Issued For Services1.85 Per Share
SharesIssuedForServices1.85PerShare
6000
CY2021Q2 clir Common Stock For Services Per Share Issue Four
CommonStockForServicesPerShareIssueFour
1.21
CY2021Q2 clir Stock Issued During Period Value Issued For Services Four
StockIssuedDuringPeriodValueIssuedForServicesFour
-72000
CY2021Q2 clir Common Stock Issued For Exercise Of Options0.98 Per Share
CommonStockIssuedForExerciseOfOptions0.98PerShare
0.98
CY2021Q2 clir Common Stock For Services2.93 Per Share Issue
CommonStockForServices2.93PerShareIssue
2.93
CY2021Q2 clir Adjustments To Additional Paid In Capital Share Based Payment Arrangement Option Increase For Cost Recognition Two
AdjustmentsToAdditionalPaidInCapitalShareBasedPaymentArrangementOptionIncreaseForCostRecognitionTwo
52000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
19000
CY2021Q2 clir Shares Issued Through Use Of At Market Issuance
SharesIssuedThroughUseOfAtMarketIssuance
1916000
CY2021Q2 clir Shares Issued For Services Per Share
SharesIssuedForServicesPerShare
2.33
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
9000
CY2021Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-2291000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11741000
us-gaap Profit Loss
ProfitLoss
-3128000
us-gaap Profit Loss
ProfitLoss
-4312000
clir Common Stock Issued For Services
CommonStockIssuedForServices
14000
clir Common Stock Issued For Services
CommonStockIssuedForServices
18000
us-gaap Share Based Compensation
ShareBasedCompensation
130000
us-gaap Share Based Compensation
ShareBasedCompensation
691000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
72000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
92000
clir Cost Of Sales On Losses Two Contracts
CostOfSalesOnLossesTwoContracts
574000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
37000
clir Gain On Forgiveness Of Payroll Protection Plan Loan
GainOnForgivenessOfPayrollProtectionPlanLoan
-251000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
448000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
590000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-33000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
260000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
81000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
102000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
175000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
225000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-46000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3347000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3674000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
73000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
69000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
37000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-94000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4798000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5309000
clir Proceeds From Exercise Of Stock Options
ProceedsFromExerciseOfStockOptions
277000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4798000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5586000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-10000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1400000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1818000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7607000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8824000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9007000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10642000
clir Officer And Employee Equity Awards For Prior Year Accrued Compensation
OfficerAndEmployeeEquityAwardsForPriorYearAccruedCompensation
107000
clir Officer And Employee Equity Awards For Prior Year Accrued Compensation
OfficerAndEmployeeEquityAwardsForPriorYearAccruedCompensation
217000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3300000
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1500000
CY2022Q3 clir Net Proceeds From Issuance Of Common Stock
NetProceedsFromIssuanceOfCommonStock
1700000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-85900000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3400000
CY2022Q2 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
758000
CY2021Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
1132000
CY2022Q2 clir Property Plant And Equipment And Operating Lease Right Of Use Asset Excluding Construction In Progress Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetExcludingConstructionInProgressAccumulatedDepreciationAndAmortization
689000
CY2021Q4 clir Property Plant And Equipment And Operating Lease Right Of Use Asset Excluding Construction In Progress Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetExcludingConstructionInProgressAccumulatedDepreciationAndAmortization
1055000
CY2022Q2 clir Property Plant And Equipment Excluding Lessor Asset Under Operating Lease And Construction In Progress After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation
69000
CY2021Q4 clir Property Plant And Equipment Excluding Lessor Asset Under Operating Lease And Construction In Progress After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation
77000
CY2022Q2 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
408000
CY2021Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
453000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
477000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
530000
us-gaap Depreciation
Depreciation
13000
us-gaap Depreciation
Depreciation
20000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
408000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
453000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
227000
clir Cost Of Sales On Losses Two Contracts
CostOfSalesOnLossesTwoContracts
574000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
205000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
252000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
350000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
479000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
555000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.058
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
46000
us-gaap Operating Lease Cost
OperatingLeaseCost
88000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
61000
us-gaap Operating Lease Cost
OperatingLeaseCost
96000
us-gaap Payments For Rent
PaymentsForRent
119000
us-gaap Payments For Rent
PaymentsForRent
124000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
25000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
320000
CY2022Q2 clir Lessee Operating Lease Liability Discounted Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityDiscountedPaymentsRemainderOfFiscalYear
131000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
143000
CY2022Q2 clir Lessee Operating Lease Liability Discounted Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths
122000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
136000
CY2022Q2 clir Lessee Operating Lease Liability Discounted Payments Due Year Two
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearTwo
54000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
65000
CY2022Q2 clir Lessee Operating Lease Liability Discounted Payments Due Year Three
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearThree
59000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
66000
CY2022Q2 clir Lessee Operating Lease Liability Discounted Payments Due Year Four
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearFour
63000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
67000
CY2022Q2 clir Lessee Operating Lease Liability Discounted Payments Due After Year Four
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueAfterYearFour
50000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
51000
CY2022Q2 clir Lessee Operating Lease Liability Discounted Payments Due
LesseeOperatingLeaseLiabilityDiscountedPaymentsDue
479000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
528000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
49000
CY2022Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1086000
CY2021Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1016000
CY2022Q2 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
99000
CY2021Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
97000
CY2022Q2 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
8000
CY2021Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
8000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1193000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1121000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
381000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
322000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
812000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
799000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
59000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
96000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
74000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
42000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9000
CY2022Q2 clir Finite Lived Intangible Assets Amortization Expense Due After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseDueAfterYearFour
12000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
292000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
505000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
730000
CY2021Q2 clir Cost Of Sales On Losses Two Contracts
CostOfSalesOnLossesTwoContracts
556000
CY2021Q2 clir Number Of Contracts Estimated Losses Included In Cost Of Sales
NumberOfContractsEstimatedLossesIncludedInCostOfSales
2
CY2021Q2 clir Reversals Of Accruals For Product Warranties That Expired
ReversalsOfAccrualsForProductWarrantiesThatExpired
35000
CY2021Q2 clir Residual Cost On Completed Contract
ResidualCostOnCompletedContract
16000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M15D
clir Number Of Contracts Estimated Losses Included In Cost Of Sales
NumberOfContractsEstimatedLossesIncludedInCostOfSales
2
clir Reversals Of Accruals For Product Warranties That Expired
ReversalsOfAccrualsForProductWarrantiesThatExpired
86000
clir Residual Cost On Completed Contract
ResidualCostOnCompletedContract
8000
CY2022Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
486000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
39000
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
62500000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000.0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.7764
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0139
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
57000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
429000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2964000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.06
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M20D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
88000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.26
clir Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y6M3D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
10000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.93
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3039000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.03
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M19D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2212000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.71
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M14D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
291000
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1700000

Files In Submission

Name View Source Status
0001558370-22-013628-index-headers.html Edgar Link pending
0001558370-22-013628-index.html Edgar Link pending
0001558370-22-013628.txt Edgar Link pending
0001558370-22-013628-xbrl.zip Edgar Link pending
clir-20220630.xsd Edgar Link pending
clir-20220630x10q.htm Edgar Link pending
clir-20220630xex10d1.htm Edgar Link pending
clir-20220630xex10d1002.jpg Edgar Link pending
clir-20220630xex31d1.htm Edgar Link pending
clir-20220630xex31d2.htm Edgar Link pending
clir-20220630xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
clir-20220630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clir-20220630_lab.xml Edgar Link unprocessable
clir-20220630x10q_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
clir-20220630_pre.xml Edgar Link unprocessable
clir-20220630_cal.xml Edgar Link unprocessable